儿童接种新型冠状病毒疫苗后发生腺肠系膜淋巴结炎：一例病例报告及文献综述
Adenomesenteritis following SARS-CoV-2 Vaccination in Children: A Case Report and Review of The Literature.
作者信息
Bloise Silvia, Marcellino Alessia, Martucci Vanessa, Sanseviero Mariateresa, Testa Alessia, Del Giudice Emanuela, Spatuzzo Mattia, Sermoneta Daniel, Ventriglia Flavia, Lubrano Riccardo
机构信息
Dipartimento Materno Infantile e di Scienze Urologiche, UOC di, Sapienza Università di Roma, 00185 Rome, Italy.
Azienda Sanitaria Locale di Latina, 04100 Latina, Italy.
出版信息
Children (Basel). 2022 Jul 1;9(7):993. doi: 10.3390/children9070993.
At present, the vaccine authorized in children aged 5 years and older is the BNT162b2 messenger RNA COVID-19 vaccine. Unlike adults, there is limited data available in the pediatric age describing adverse events after vaccine. We report a case of adenomesenteritis in a young girl following the first dose of vaccine.
目前，5岁及以上儿童获批使用的疫苗是BNT162b2信使核糖核酸新冠疫苗。与成人不同，关于儿科年龄段疫苗接种后不良事件的数据有限。我们报告了一名年轻女孩在接种第一剂疫苗后发生腺性肠系膜淋巴结炎的病例。
Zotero 插件